@article{SchwitterWackerWilkeetal.2012,
  author    = {Schwitter, Juerg and Wacker, Christian M. and Wilke, Norbert and Al-Saadi, Nidal and Sauer, Ekkehart and Huettle, Kalman and Sch{\"o}nberg, Stefan O. and Debl, Kurt and Strohm, Oliver and Ahlstrom, Hakan and Dill, Thorsten and Hoebel, Nadja and Simor, Tamas},
  title     = {Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicenter multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coronary Artery Disease Trial)},
  series = {Journal of Cardiovascular Magnetic Resonance},
  volume    = {14},
  journal   = {Journal of Cardiovascular Magnetic Resonance},
  number    = {61},
  organization    = {MR-IMPACT investigators},
  doi       = {10.1186/1532-429X-14-61},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-134256},
  year      = {2012},
  abstract  = {Background: Perfusion-cardiovascular magnetic resonance (CMR) is generally accepted as an alternative to SPECT to assess myocardial ischemia non-invasively. However its performance vs gated-SPECT and in sub-populations is not fully established. The goal was to compare in a multicenter setting the diagnostic performance of perfusion-CMR and gated-SPECT for the detection of CAD in various populations using conventional x-ray coronary angiography (CXA) as the standard of reference. Methods: In 33 centers (in US and Europe) 533 patients, eligible for CXA or SPECT, were enrolled in this multivendor trial. SPECT and CXA were performed within 4 weeks before or after CMR in all patients. Prevalence of CAD in the sample was 49\% and 515 patients received MR contrast medium. Drop-out rates for CMR and SPECT were 5.6\% and 3.7\%, respectively (ns). The study was powered for the primary endpoint of non-inferiority of CMR vs SPECT for both, sensitivity and specificity for the detection of CAD (using a single-threshold reading), the results for the primary endpoint were reported elsewhere. In this article secondary endpoints are presented, i.e. the diagnostic performance of CMR versus SPECT in subpopulations such as multi-vessel disease (MVD), in men, in women, and in patients without prior myocardial infarction (MI). For diagnostic performance assessment the area under the receiver-operator-characteristics-curve (AUC) was calculated. Readers were blinded versus clinical data, CXA, and imaging results. Results: The diagnostic performance (= area under ROC = AUC) of CMR was superior to SPECT (p = 0.0004, n = 425) and to gated-SPECT (p = 0.018, n = 253). CMR performed better than SPECT in MVD (p = 0.003 vs all SPECT, p = 0.04 vs gated-SPECT), in men (p = 0.004, n = 313) and in women (p = 0.03, n = 112) as well as in the non-infarct patients (p = 0.005, n = 186 in 1-3 vessel disease and p = 0.015, n = 140 in MVD). Conclusion: In this large multicenter, multivendor study the diagnostic performance of perfusion-CMR to detect CAD was superior to perfusion SPECT in the entire population and in sub-groups. Perfusion-CMR can be recommended as an alternative for SPECT imaging.},
  language  = {en}
}
@article{KaireitSorrentinoRenneetal.2017,
  author    = {Kaireit, Till F. and Sorrentino, Sajoscha A. and Renne, Julius and Schoenfeld, Christian and Voskrebenzev, Andreas and Gutberlet, Marcel and Schulz, Angela and Jakob, Peter M. and Hansen, Gesine and Wacker, Frank and Welte, Tobias and T{\"u}mmler, Burkhard and Vogel-Claussen, Jens},
  title     = {Functional lung MRI for regional monitoring of patients with cystic fibrosis},
  series = {PLoS ONE},
  volume    = {12},
  journal   = {PLoS ONE},
  number    = {12},
  doi       = {10.1371/journal.pone.0187483},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-172457},
  year      = {2017},
  abstract  = {Purpose To test quantitative functional lung MRI techniques in young adults with cystic fibrosis (CF) compared to healthy volunteers and to monitor immediate treatment effects of a single inhalation of hypertonic saline in comparison to clinical routine pulmonary function tests. Materials and methods Sixteen clinically stable CF patients and 12 healthy volunteers prospectively underwent two functional lung MRI scans and pulmonary function tests before and 2h after a single treatment of inhaled hypertonic saline or without any treatment. MRI-derived oxygen enhanced T1 relaxation measurements, fractional ventilation, first-pass perfusion parameters and a morpho-functional CF-MRI score were acquired. Results Compared to healthy controls functional lung MRI detected and quantified significantly increased ventilation heterogeneity in CF patients. Regional functional lung MRI measures of ventilation and perfusion as well as the CF-MRI score and pulmonary function tests could not detect a significant treatment effect two hours after a single treatment with hypertonic saline in young adults with CF (p>0.05). Conclusion This study shows the feasibility of functional lung MRI as a non-invasive, radiation-free tool for monitoring patients with CF.},
  language  = {en}
}